Shennon Biotechnologies analyzes and manipulates a massive number of cells on the single-cell level to develop more effective treatments for human diseases. It functionally profiles millions of immune cells to find the best targets for cancer immunotherapy. Backed by Foundation Capital.
About the role
Reporting directly to the Chief Technology Officer, the Associate Director of Droplet-based Microfluidics Applications should be an experienced leader with hands-on expertise in droplet-based microfluidic applications (such as droplet-based sequencing and/or droplet-based screening), who can think across biology and engineering to drive solutions in functional biology, and find new preclinical or clinical applications.
What they're looking for
- Multi-disciplinary in training, with experience across disciplinary boundaries, can think across biology and engineering, has worked in a multi-disciplinary team
- 3+ years of leadership experience in industry, have managed a team, led projects and delivered results within defined timelines
- Demonstrated adaptability and maturity in aligning with the company's directions and needs
- Awareness of one’s own strength and weaknesses, low ego, growth mindset, comfortable changing course as priorities evolve
- Understands the startup environment and passionate about it
- Ability to gauge each team member’s strengths and weaknesses and know how to get the best out of each person in the team
More about this role
Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional screening, computational binder design and predictive safety assessment. In particular, where conventional discovery tests binders sequentially over months, our functional screening platform TCELERATOR profiles more than 10 million single-cell interactions at once, identifying functional leads in a single experiment. The unified engine is supported by proprietary human tumor datasets and an expanding network of academic and clinical collaborators. We are developing both antibody-based and TCR-based T-cell engagers designed to address surface and intracellular cancer targets. Our initial oncology pipeline includes programs in small cell lung cancer, ovarian cancer and hepatocellular carcinoma. We are based in the dogpatch neighborhood of San Francisco with 6000 sqft of lab space. For more information, visit www.shennonbio.com.
Reporting directly to the Chief Technology Officer, the Associate Director of Droplet-based Microfluidics Applications should be an experienced leader with...
Browse similar: Startup jobs · San Francisco Bay Area